Clinical Trials in Georgetown, United States
Locations / Georgetown, United States
Delta Trials records 255 clinical trials conducted in Georgetown, United States, making it a notable site of clinical research activity. These trials across 556 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 16 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Georgetown has changed over time.
255
Total Trials
556
Conditions
16
Terminated since 2020
Browse by condition (556 total)
- Diabetes mellitus, type 2 12 trialsAll Diabetes mellitus, type 2 trials
- Parkinson's disease 10 trialsAll Parkinson's disease trials
- All Recurrent squamous cell lung carcinoma trials
- All Stage iv squamous cell lung carcinoma ajcc v7 trials
- Breast cancer 8 trialsAll Breast cancer trials
- Asthma 6 trialsAll Asthma trials
- Hypertension 6 trialsAll Hypertension trials
- Invasive breast carcinoma 6 trialsAll Invasive breast carcinoma trials
- All Hematopoietic and lymphoid cell neoplasm trials
- Breast carcinoma 5 trialsAll Breast carcinoma trials
- Type 2 diabetes 4 trialsAll Type 2 diabetes trials
- Ulcerative colitis 4 trialsAll Ulcerative colitis trials
- Obesity 4 trialsAll Obesity trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- All Anatomic stage ii breast cancer ajcc v8 trials
- All Atherosclerotic cardiovascular disease trials
- Stage iiia breast cancer 3 trialsAll Stage iiia breast cancer trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Melanoma 3 trialsAll Melanoma trials
- Essential tremor 3 trialsAll Essential tremor trials